Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;10(2):83-6.
doi: 10.1080/13651820801992609.

Pathological aspects of cholangiocarcinoma

Affiliations

Pathological aspects of cholangiocarcinoma

I Esposito et al. HPB (Oxford). 2008.

Abstract

Cholangiocarcinoma (CC) arises from the biliary epithelium and in most cases represents adenocarcinoma. Pathomorphological evaluation is of decisive impact for the prognosis and management of CC. Morphological subtyping (histotype; hilar vs peripheral type), TNM classification, lymphatic spread, and resection margin status are of prognostic relevance. Distinction from hepatic metastases may be aided by immunohistology and clinico-pathological correlation. There is convincing evidence of the development of CC via premalignant lesions, especially biliary intraepithelial neoplasia, although further knowledge about the biology and diagnostic definition of these lesions has to be accumulated. Currently, there are no established molecular markers of prognosis or therapeutic target structures to be evaluated at the tissue level. Future progress is needed and expected in novel differential diagnostic and predictive markers, in uniform definition of resection margin status and further understanding of molecular and morphological changes in the development of CC.

Keywords: Bile duct; bile duct cancer; cholangiocarcinoma; histopathology; resection margin.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–25. - PubMed
    1. Nakeeb A, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463–73; discussion 473–5. - PMC - PubMed
    1. DeOliveira ML, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755–62. - PMC - PubMed
    1. Ishak KG, Goodman ZD, Stocker JT. Rosai J, Sobin LH. AFIP; Washington: 2001. Intarhepatic cholangiocarcinoma and other malignant biliary tumors, Tumors of the liver and intrahepatic bile ducts; pp. 245–70.
    1. Sasaki A, et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg. 1998;85:1206–9. - PubMed

LinkOut - more resources